¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛ ½ÃÀåÀº 2024-2028³â ¿¹Ãø ±â°£ µ¿¾È ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
ÀÇ·á Àü¹®°¡¿Í ÀÏ¹Ý ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁö°í Àü ¼¼°èÀûÀ¸·Î Ç÷¾× ¹× Ç÷¾× Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù.
Ç÷¾× °ü¸® ½Ã½ºÅÛÀº ÀÇ·á ÇöÀå¿¡¼ Ç÷¾× Á¦Á¦ »ç¿ëÀ» ÃÖÀûÈÇϱâ À§ÇØ °í¾ÈµÈ ÀÏ·ÃÀÇ Àü·«, ±â¼ú ¹× ÇÁ·Î¼¼½º¸¦ ¸»ÇÕ´Ï´Ù. Ç÷¾× °ü¸®ÀÇ ÁÖ¿ä ¸ñÇ¥´Â ¼öÇ÷ÀÇ Çʿ伺À» ÃÖ¼ÒÈÇÏ¸é¼ È¯ÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇϰí ȯÀÚÀÇ °á°ú¸¦ °³¼±ÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÀϹÝÀûÀ¸·Î º´¿ø, ¼ö¼ú ¼¾ÅÍ ¹× ±âŸ ÀÇ·á ½Ã¼³¿¡ µµÀԵ˴ϴÙ. ¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇÏ´Â ´Ù¸¥ ¿äÀÎÀ¸·Î´Â ÇåÇ÷ ¼ö¿ä Áõ°¡, ±â¼ú ¹ßÀü, ÀÇ·áºñ ÁöÃâ Áõ°¡, Ç÷¾× ÁúȯÀÇ À¯º´·ü Áõ°¡, ÇåÇ÷ÀÚ ¼ö Áõ°¡, ¼ö¼ú °Ç¼ö Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù.
2021³â Àεµ ±¹°¡ ¿¡ÀÌÁî ´ëÃ¥±â±¸´Â ¼öÇ÷ ¼ºñ½º¸¦ ÅëÇØ ¾à 583¸¸ ´ÜÀ§ÀÇ Ç÷¾× ¼öÁýÀ» ÃËÁøÇß½À´Ï´Ù. ÀÌ´Â ¾à 730¸¸ ´ÜÀ§°¡ ¼öÁýµÈ Àü³â ´ëºñ °¨¼ÒÇÑ ¼öÄ¡ÀÔ´Ï´Ù. ¶ÇÇÑ, Ç÷¾× °ü¸® ½Ã½ºÅÛ Ã¤Åÿ¡ Àμ¾Æ¼ºê¸¦ Á¦°øÇÏ´Â À¯¸®ÇÑ »óȯ Á¤Ã¥ ¹× ¸ÞÄ¿´ÏÁòÀº ¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛ ½ÃÀå ¼ºÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ À¯¸®ÇÑ »óȯ Á¤Ã¥Àº ÀÇ·á ¼ºñ½º Á¦°øÀÚ°¡ ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡ ÅõÀÚÇϰí Ç÷¾× °ü¸® ¸ð¹ü »ç·Ê¸¦ ±¸ÇöÇϵµ·Ï Àå·ÁÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå °³¿ä | |
---|---|
¿¹Ãø ±â°£ | 2024-2028 |
2022³â ½ÃÀå ±Ô¸ð | 142¾ï 8,000¸¸ ´Þ·¯ |
2028³â ½ÃÀå ±Ô¸ð | 227¾ï 2,700¸¸ ´Þ·¯ |
CAGR 2023-2028 | 8.34% |
±Þ¼ºÀå ºÎ¹® | ÀüÇ÷ |
ÃÖ´ë ½ÃÀå | ºÏ¹Ì |
Ç÷¾× ¹× Ç÷¾×Á¦Á¦ ¼ö¿ä È®´ë
Ç÷¾× ¹× Ç÷¾× Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È ¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ö¼ú, ¾Ï Ä¡·á, Àå±â À̽ÄÀ» Æ÷ÇÔÇÑ ´Ù¾çÇÑ ÀÇÇÐÀû »óÅ´ ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇØ ¼öÇ÷ÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼öÇ÷ÀÇ Çʿ伺 Áõ°¡´Â °í±Þ Ç÷¾× °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä¸¦ Á÷Á¢ÀûÀ¸·Î ÃËÁøÇϰí ÀÖÀ¸¸ç, 2021³â ¹Ì±¹ Àû½ÊÀÚ»ç´Â ¹Ì±¹¿¡¼ °â»óÀûÇ÷±¸ÁõÈıºÀÌ ¾à 100¸¸ ¸í¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ È¯ÀÚµéÀº Æò»ý µ¿¾È ¼öÇ÷ÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ¼öÇ÷¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ±â°üÀº Áõ°¡ÇÏ´Â ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ Ç÷¾× Àç°í, ÃßÀû ¹× ¼öÇ÷ °úÁ¤À» È¿À²ÀûÀ¸·Î °ü¸®ÇØ¾ß ÇÒ Çʿ伺À» ÀνÄÇϰí Àֱ⠶§¹®¿¡ Ç÷¾× ¹× Ç÷¾× Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â Ç÷¾× °ü¸® ½Ã½ºÅÛÀÇ Ã¤Åðú ÇÔ²² ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, Ç÷¾× °ü¸® ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÏ¿© ¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.
ÇコÄɾî Àü¹®°¡¿Í ÀÏ¹Ý ´ëÁßÀÇ ÀÎ½Ä Á¦°í
Ç÷¾× °ü¸®ÀÇ Á߿伺¿¡ ´ëÇÑ ÀÇ·á Àü¹®°¡¿Í ÀÏ¹Ý ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁö´Â °Íµµ ¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛ ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ÀÇ»ç, °£È£»ç, °Ë»ç Á÷¿øÀ» Æ÷ÇÔÇÑ ÀÇ·á Àü¹®°¡µéÀº ÀûÀýÇÑ Ç÷¾× °ü¸® °üÇàÀÇ Á߿伺À» ÀνÄÇϰí ÀÖ½À´Ï´Ù. ±×µéÀº °¨¿°, ¼öÇ÷ ¹ÝÀÀ, ÀÚ¿ø ³¶ºñ µî ºÒÇÊ¿äÇÑ ¼öÇ÷°ú °ü·ÃµÈ ÀáÀçÀû À§Çè¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀνÄÀº ÀÇ·á Àü¹®°¡µéÀÌ Ç÷¾× °ü¸® ½Ã½ºÅÛÀ» µµÀÔÇÏ¿© Ç÷¾× Ȱ¿ëÀ» ÃÖÀûÈÇϰí ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ ¾ÈÀü°ú Ä¡·áÀÇ Áú¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á Àü¹®°¡µéÀº Ç¥ÁØÈµÈ Ç÷¾× °ü¸® ÇÁ·ÎÅäÄÝÀ» ½ÃÇàÇÏ´Â °ÍÀÌ Áß¿äÇÏ´Ù´Â °ÍÀ» ÀνÄÇϰí ÀÖ½À´Ï´Ù. Ç÷¾× °ü¸® ½Ã½ºÅÛÀº ÀûÀýÇÑ Ç÷¾× Á¦Á¦ »ç¿ëÀ» º¸ÀåÇϰí, ¼öÇ÷ °ü·Ã ÇÕº´Áõ À§ÇèÀ» ÁÙÀ̸ç, Àü¹ÝÀûÀÎ ÀÇ·á °á°ú¸¦ °³¼±ÇÏ¿© ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½ÃŰ´Â µµ±¸¿Í ÁöħÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÀÇ·á ºñ¿ë¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á Á¾»çÀÚµéÀº ºñ¿ë Àý°¨À» À§ÇÑ Àü·«À» ¸ð»öÇϰí ÀÖ½À´Ï´Ù. Ç÷¾× °ü¸® ½Ã½ºÅÛÀº Ç÷¾× Á¦Á¦ »ç¿ëÀ» ÃÖÀûÈÇÏ°í ºÒÇÊ¿äÇÑ ¼öÇ÷À» ÁÙÀÌ¸ç ³¶ºñ¸¦ ÃÖ¼ÒÈÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» µµÀÔÇÔÀ¸·Î½á ÀÇ·á ±â°üÀº ÇÊ¿äÇÑ È¯ÀÚ¿¡°Ô ÃæºÐÇÑ °ø±ÞÀ» º¸ÀåÇÏ¸é¼ ºñ¿ë Àý°¨À» ´Þ¼ºÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» °ÈÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¶ÇÇÑ, ÀÇ·á °ü·Ã ¹®Á¦¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼ ¼öÇ÷°ú ¼öÇ÷ÀÇ ÀáÀçÀû À§Çè°ú ÀÌÁ¡¿¡ ´ëÇÑ ÀÌÇØµµ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ȯÀÚµéÀº ÀÇ·áÁø°ú Ä¡·á ¿É¼Ç¿¡ ´ëÇØ Àû±ØÀûÀ¸·Î ³íÀÇÇϰí, ÀûÀýÇÑ °æ¿ì ¼öÇ÷¿¡ ´ëÇÑ ´ë¾ÈÀ» ¸ð»öÇÏ´Â °æÇâÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È¯ÀÚ ÀνÄÀÇ Çâ»ó°ú ±ÇÇÑ ºÎ¿©·Î ÀÎÇØ ÀÇ·á ±â°üÀº ȯÀÚ Áß½É Ä¡·á¸¦ Áö¿øÇϰí, ¼ö¼ú Áß ¼¼Æ÷ ±¸Á¦ ¹× ÃÖ¼Ò Ä§½ÀÀû ½Ã¼ú°ú °°Àº ¼öÇ÷ ´ë¾ÈÀ» Á¦°øÇÏ´Â Ç÷¾× °ü¸® ½Ã½ºÅÛÀ» µµÀÔÇϰí ÀÖ½À´Ï´Ù. Àü±¹¼öÇ÷ÇùÀÇȸ(NBTC) ÇÁ·Î±×·¥, ±¹Á¦È¯ÀÚÇ÷¾×°ü¸®Àç´Ü(IFPBM) µî Ç÷¾× °ü¸® ½Ã½ºÅÛ »ç¿ëÀ» ÃËÁøÇÏ´Â ´Ù¾çÇÑ ÇÁ·Î±×·¥°ú ÀÌ´Ï¼ÅÆ¼ºê°¡ ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ±¹Á¦È¯ÀÚÇ÷¾×°ü¸®Àç´Ü(IFPBM)Àº ȯÀÚÀÇ Ç÷¾× °ü¸®¸¦ ÃËÁøÇϰí ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÏ´Â ¼¼°è Á¶Á÷À¸·Î, ±³À° ÄÁÆÛ·±½º, ¿öÅ©¼¥, ¿þºñ³ª µîÀ» °³ÃÖÇÏ¿© Ç÷¾× °ü¸® ½Ã½ºÅÛÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̰í Àü ¼¼°è ÀÇ·á ÇöÀå¿¡¼ÀÇ µµÀÔ µµÀÔÀ» ÁöÁöÇϰí ÀÖ½À´Ï´Ù.
±â¼úÀÇ ¹ßÀü
±â¼úÀÇ ¹ßÀüÀº ¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀå¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº Çõ½ÅÀûÀÎ ±â´ÉÀ» µµÀÔÇÏ°í ½Ã½ºÅÛ ±â´ÉÀ» °³¼±ÇÏ¿© Àü¹ÝÀûÀÎ È¿À²¼º°ú ȯÀÚ ¾ÈÀüÀ» Çâ»ó½ÃÄ×½À´Ï´Ù. ¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ£ ÁÖ¿ä ±â¼ú ¹ßÀü¿¡´Â ÀÚµ¿È ¹× ÅëÇÕ, ¹ÙÄÚµå ½ºÄ³´× ¹× RFID ±â¼ú, ÀΰøÁö´É(AI) µîÀÌ ÀÖ½À´Ï´Ù.
ÀÚµ¿È ¹× ÅëÇÕÀ» ÅëÇØ Ç÷¾× °ü¸® ½Ã½ºÅÛÀº Àç°í ÃßÀû, ȯÀÚ ½Äº°, ¼öÇ÷ ¹®¼È µî Ç÷¾× °ü¸®¿Í °ü·ÃµÈ ´Ù¾çÇÑ ÇÁ·Î¼¼½º¸¦ ÀÚµ¿ÈÇÏ´Â ¹æÇâÀ¸·Î ¹ßÀüÇϰí ÀÖ½À´Ï´Ù. ÀüÀÚ ÀÇ·á ±â·Ï(EHR) ¹× ±âŸ ÀÇ·á ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀ» ÅëÇØ ¿øÈ°ÇÑ µ¥ÀÌÅÍ ±³È¯ÀÌ °¡´ÉÇØÁ® ¼öÀÛ¾÷À¸·Î ÀÎÇÑ ½Ç¼ö¸¦ ÁÙÀ̰í, ¿öÅ©Ç÷οìÀÇ È¿À²¼ºÀ» ³ôÀ̸ç, ȯÀÚÀÇ ¾ÈÀü¼ºÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ½ºÄ³´× ¹× RFID ±â¼úÀº ¹ÙÄÚµå ½ºÄ³´×°ú ¹«¼± ÀÚµ¿ ½Äº°(RFID) ±â¼úÀÇ »ç¿ëÀ¸·Î Ç÷¾× °ü¸® ½Ã½ºÅÛ¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ¹ÙÄÚµå¿Í RFID ű״ °ø±Þ¸Á Àü¹Ý¿¡ °ÉÃÄ Ç÷¾× Á¦Á¦¸¦ ÃßÀûÇÏ°í ½Äº°ÇÏ´Â µ¥ »ç¿ëµÇ¾î ȯÀÚ¿ÍÀÇ Á¤È®ÇÑ ¸ÅĪÀ» º¸ÀåÇÏ°í ¿À·ùÀÇ À§ÇèÀ» ÁÙÀ̸ç ÃßÀû¼ºÀ» °ÈÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ÇÁ·Î¼¼½º¸¦ °£¼ÒÈÇϰí Àç°í °ü¸®¸¦ °³¼±Çϸç Àü¹ÝÀûÀÎ ¼öÇ÷ ¾ÈÀü¿¡ ±â¿©ÇÕ´Ï´Ù. ´Ù¸¥ ±â¼ú ¹ßÀüÀ¸·Î´Â ÀüÀÚ ±³Â÷ ¸Åΰú ÀûÇÕ¼º Å×½ºÆ®°¡ ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ ±³Â÷ ¸ÅĪ ¹× ÀûÇÕ¼º °Ë»ç ¹æ¹ýÀº ½Ã°£°ú ÀÚ¿øÀÌ ¸¹ÀÌ ¼Ò¿äµË´Ï´Ù. ÷´Ü Ç÷¾× °ü¸® ½Ã½ºÅÛÀº ¾Ë°í¸®Áò°ú ȯÀÚ µ¥ÀÌÅ͸¦ »ç¿ëÇÏ¿© Ç÷¾× ÀûÇÕ¼ºÀ» ¿¹ÃøÇÏ´Â ÀüÀÚ ±³Â÷ ¸ÅĪ ±â´ÉÀ» ÅëÇÕÇÏ¿© Ç÷ûÇÐÀû °Ë»çÀÇ Çʿ伺À» ÁÙÀÌ°í ¼öÇ÷ °úÁ¤À» °¡¼ÓÈÇÕ´Ï´Ù. ÀÌ ±â¼úÀº ¹è¼Û ½Ã°£À» °³¼±ÇÏ°í ºñ¿ëÀ» Àý°¨Çϸç ȯÀÚ Ä¡·á¸¦ °³¼±ÇÕ´Ï´Ù. ¶ÇÇÑ Ç÷¾× °ü¸® ½Ã½ºÅÛ¿¡´Â ÀÇ»ç °áÁ¤ Áö¿ø ½Ã½ºÅÛ°ú ¿¹Ãø ºÐ¼®ÀÌ ³»ÀåµÇ¾î ÀÖ¾î ÀÇ·á Àü¹®°¡°¡ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ȯÀÚ µ¥ÀÌÅÍ, Ç÷¾× Á¦Á¦ °¡¿ë¼º, °ú°Å ¼öÇ÷ ÆÐÅÏÀ» ºÐ¼®ÇÏ¿© ÃÖÀûÀÇ Ç÷¾× »ç¿ë, Àç°í °ü¸® ¹× ¼öÇ÷ Àü·«À» Á¦¾ÈÇÕ´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°øÀÚ´Â µ¥ÀÌÅÍ ÀλçÀÌÆ®¸¦ Ȱ¿ëÇÏ¿© ȯÀÚ °á°ú¸¦ °³¼±Çϰí, ºñ¿ëÀ» Àý°¨Çϸç, ÀÚ¿ø ¹èºÐÀ» °ÈÇÒ ¼ö ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ǰú ¿ø°Ý ¾×¼¼½º ±â´ÉÀ» ÅëÇØ Ç÷¾× °ü¸® ½Ã½ºÅÛÀº ÀÇ·á Àü¹®°¡¿¡°Ô ´õ¿í Ä£¼÷ÇÏ°í Æí¸®ÇÏ°Ô ´Ù°¡°¥ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀ» ÅëÇØ ÀÇ·á ¼ºñ½º Á¦°øÀÚ´Â ½Ç½Ã°£ µ¥ÀÌÅÍ¿¡ ¾×¼¼½ºÇϰí, ¿ø°ÝÀ¸·Î ÀÛ¾÷À» ¼öÇàÇϰí, À̵¿ Áß¿¡µµ Áß¿äÇÑ °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ¾ÖÇø®ÄÉÀ̼ÇÀº È¿À²ÀûÀÎ Ä¿¹Â´ÏÄÉÀ̼ÇÀ» °¡´ÉÇÏ°Ô Çϰí, ¼·ù ÀÛ¾÷À» ÁÙÀ̸ç, ÀÇ·á ÆÀ °£ÀÇ Çù¾÷À» °ÈÇÏ¿© Ç÷¾× °ü¸® ¾÷¹«¸¦ °³¼±ÇÏ´Â µ¥ ±â¿©ÇÕ´Ï´Ù. ¶ÇÇÑ, ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÇ ÅëÇÕÀº Ç÷¾× °ü¸® ½Ã½ºÅÛÀÇ ´Ù¾çÇÑ ÇÁ·Î¼¼½º¸¦ ÃÖÀûÈÇϱâ À§ÇØ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ´ë·®ÀÇ µ¥ÀÌÅ͸¦ ºÐ¼®Çϰí, ÆÐÅÏÀ» ½Äº°Çϰí, ÀÇ»ç °áÁ¤, Àç°í ¿¹Ãø, ¸ÂÃãÇü ¼öÇ÷ Àü·«À» Áö¿øÇϱâ À§ÇÑ ¿¹ÃøÀ» ÇÒ ¼ö ÀÖÀ¸¸ç, AI ±â¹Ý ½Ã½ºÅÛÀº ÀáÀçÀû ºÎÀÛ¿ëÀ» ½Äº°Çϰí, Ç÷¾× Á¦Á¦ ¸ÅĪÀ» °³¼±Çϰí, ȯÀÚ ¾ÈÀüÀ» Çâ»ó½ÃŰ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀÇ Áõ°¡´Â Ç÷¾× °ü¸® ȯ°æÀ» º¯È½ÃŰ°í ¾÷¹« È¿À²¼º, ȯÀÚ ¾ÈÀü, ÀÚ¿ø Ȱ¿ëµµ¸¦ Çâ»ó½ÃÄÑ Àü ¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛÀÇ ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.
ÃÖ±Ù µ¿Çâ
½ÃÀå ¼¼ºÐÈ
°æÀï »óȲ
±â¾÷ °³¿ä : ¼¼°è Ç÷¾× °ü¸® ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷¿¡ ´ëÇÑ ½ÉÃþ ºÐ¼®
»ç¿ë °¡´ÉÇÑ Ä¿½ºÅ͸¶ÀÌ¡ :
TechSci Research´Â ÁÖ¾îÁø ½ÃÀå µ¥ÀÌÅ͸¦ ¹ÙÅÁÀ¸·Î ±â¾÷ÀÇ °íÀ¯ÇÑ Çʿ信 µû¶ó ¸ÂÃãÇüÀ¸·Î Á¦°øÇÕ´Ï´Ù. º¸°í¼¿¡¼ ´ÙÀ½°ú °°Àº Ä¿½ºÅ͸¶ÀÌ¡ÀÌ °¡´ÉÇÕ´Ï´Ù.
±â¾÷ Á¤º¸
Global blood management system market is anticipated to grow at a rapid pace in the forecast period, 2024-2028. Growing awareness among healthcare professionals and the public, coupled with the increasing demand for blood and blood products across the world are the key factors responsible for the growth of the global blood management system market.
A blood management system refers to a set of strategies, techniques, and processes designed to optimize the use of blood products in medical settings. The primary goal of blood management is to ensure patient safety and improve patient outcomes while minimizing the need for blood transfusions. These systems are typically implemented in hospitals, surgical centers, and other healthcare facilities. The other factors which are supporting the growth of the global blood management system market are growing demand for blood donations, rising technological advancements, increasing healthcare expenditure, rising prevalence of blood disorders, rise in number of blood donors, and increase in the number of surgical procedures.
In 2021, the National AIDS Control Organization in India facilitated the collection of approximately 5.83 million blood units through its blood transfusion services. This represented a decline from the previous year, when nearly 7.3 million units were collected. Additionally, favorable reimbursement policies and mechanisms that incentivize the adoption of blood management systems can positively impact the growth of the global blood management system market. Also, these favorable reimbursement policies support to encourage healthcare providers to invest in these systems and implement best practices in blood management.
Market Overview | |
---|---|
Forecast Period | 2024-2028 |
Market Size 2022 | USD 14.28 Billion |
Market Size 2028 | USD 22.72 Billion |
CAGR 2023-2028 | 8.34% |
Fastest Growing Segment | Whole Blood |
Largest Market | North America |
Growing Demand for Blood and Blood Products
The growing demand for blood and blood products is expected to bolster the growth of the global blood management system market in the coming years. Various medical conditions, including surgeries, cancer treatments, and organ transplants, necessitate blood transfusions to improve patient outcomes. This growing need for blood transfusions directly drives the demand for advanced blood management systems. In 2021, the American Red Cross stated that sickle cell disease affected about 1,00,000 people in the United Stated. These patients require blood transfusion throughout their lives, therefore increasing the demand for blood transfusions. The growing demand for blood and blood products is surging with the adoption of blood management systems, as healthcare facilities recognize the need for efficient management of blood inventory, tracking, and transfusion processes to meet the rising demand. As a result, the demand for blood management systems is surging, thereby driving the growth of the global blood management system market.
Growing Awareness among Healthcare Professionals and the Public
Growing awareness among healthcare professionals and the public about the importance of blood management is another factor influencing the global blood management system market. Healthcare professionals, including physicians, nurses, and laboratory staff, are increasingly recognizing the significance of proper blood management practices. They are becoming more aware of the potential risks associated with unnecessary blood transfusions, such as infections, transfusion reactions, and resource wastage. This awareness drives the adoption of blood management systems that help healthcare professionals make informed decisions, optimize blood utilization, and improve patient outcomes. Also, with a greater focus on patient safety and quality of care, healthcare professionals are realizing the importance of implementing standardized blood management protocols. Blood management systems provide tools and guidelines that enhance patient safety by ensuring appropriate blood product utilization, reducing the risk of transfusion-related complications, and improving overall healthcare outcomes. Furthermore, the increasing awareness of healthcare costs has prompted healthcare professionals to explore strategies for cost containment. Blood management systems help optimize blood product utilization, reduce unnecessary transfusions, and minimize wastage. By implementing these systems, healthcare facilities can achieve cost savings while ensuring adequate supply for patients in need, which in turn, is expected to strengthen the growth of the global blood management system market.
In addition, the public's growing awareness of healthcare-related issues extends to the understanding of blood transfusions and their potential risks and benefits. Patients are more likely to be proactive in discussing their treatment options with healthcare providers and seeking alternatives to blood transfusions when appropriate. This growing patient awareness and empowerment are driving healthcare facilities to adopt blood management systems that support patient-centered care and provide alternatives to transfusions, such as intraoperative cell salvage or minimally invasive procedures. There are various programs and initiatives that promote the use of blood management systems such as National Blood Transfusion Council (NBTC) Programs, International Foundation for Patient Blood Management (IFPBM), etc. For instance, the International Foundation for Patient Blood Management (IFPBM) is a global organization dedicated to promoting patient blood management and improving patient outcomes. They organize educational conferences, workshops, and webinars to raise awareness about the benefits of blood management systems and advocate for their implementation in healthcare settings worldwide.
Technological Advancements
Technological advancements have been instrumental in influencing the growth of the global blood management system market. These advancements have introduced innovative features, improved system capabilities, and enhanced overall efficiency and patient safety. Some of the key technological advancements that have influenced the growth of the global blood management system market are automation and integration, barcode scanning and RFID technology, artificial intelligence (AI), and others.
In automation and integration, blood management systems have evolved to automate various processes involved in blood management, including inventory tracking, patient identification, and transfusion documentation. Integration with electronic health records (EHRs) and other healthcare systems enables seamless data exchange, reducing manual errors, improving workflow efficiency, and enhancing patient safety. In scanning and RFID technology, the use of barcode scanning, and radio-frequency identification (RFID) technology has revolutionized blood management systems. Barcodes and RFID tags are used to track and identify blood products throughout the supply chain, ensuring accurate matching with patients, reducing the risk of errors, and enhancing traceability. These technologies streamline processes, improve inventory management, and contribute to overall transfusion safety. Other technological advancements are electronic crossmatching and compatibility testing. Traditional crossmatching and compatibility testing methods are time-consuming and resource intensive. Advanced blood management systems incorporate electronic crossmatching capabilities, using algorithms and patient data to predict blood compatibility, reducing the need for serological testing and expediting the transfusion process. This technology improves turnaround time, reduces costs, and enhances patient care. Also, blood management systems are incorporating decision support systems and predictive analytics to aid healthcare professionals in making informed decisions. These systems analyze patient data, blood product availability, and historical transfusion patterns to provide recommendations for optimal blood utilization, inventory management, and transfusion strategies. By leveraging data insights, healthcare providers can improve patient outcomes, reduce costs, and enhance resource allocation. The use of mobile applications and remote access capabilities have made blood management systems more accessible and convenient for healthcare professionals. With these technologies, healthcare providers can access real-time data, perform tasks remotely, and make critical decisions on the go. Mobile applications enable efficient communication, reduce paperwork, and enhance collaboration among healthcare teams, contributing to improved blood management practices. Furthermore, the incorporation of Artificial Intelligence (AI) and machine learning algorithms are done to optimize various processes in blood management system. These technologies can analyze large volumes of data, identify patterns, and make predictions to support decision-making, inventory forecasting, and personalized transfusion strategies. AI-powered systems can help identify potential adverse events, improve blood product matching, and enhance patient safety. These growing technological advancements are transforming the blood management landscape, and are improving operational efficiency, patient safety, and resource utilization, which in turn, supports the growth of the global blood management systems.
Recent Developments
Market Segmentation
Global blood management system market is segmented based on type, end user, company, and region. Based on type, the global blood management system market is segmented into donor management module, transfusion service module, inventory management, donation scheduling, screening & testing, reporting & analytics, integration & interoperability, and others. Based on end user, the global blood management system market is divided into blood banks, hospitals, ambulatory care centers, and others. In terms of region, the global blood management system market is divided into North America, Europe, Asia Pacific, South America, and Middle East & Africa.
Market Players
Cerner Corporation, Haemonetics Corporation, Coelentera Technologies Pvt. Ltd., Strides Software Solutions Pvt Ltd., McKesson Corporation, Integrated Medical Systems, Inc., MAK-SYSTEM International Group, Mediware, Inc., CompuGroup Medical SE & Co. KGaA, and SCC Soft Computer are some of the major leading players of the global blood management system market.
Report Scope:
In this report, global blood management system market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the global blood management system market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information